Grupo de fisiopatología y terapéutica neurológica del Instituto del Niño y del Adolescente (INA) del Hospital Clínico San Carlos
NEURO-INA-IN
Fundación Hospital Alcorcón
Alcorcón, EspañaPublications en collaboration avec des chercheurs de Fundación Hospital Alcorcón (28)
2020
-
Holistic approach of the care of the infant with hypoxic-ischaemic encephalopathy in Spain
Anales de Pediatria, Vol. 92, Núm. 5, pp. 286-296
2019
-
Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats
Frontiers in Pharmacology, Vol. 10, Núm. SEP
-
aEEG and neurologic exam findings correlate with hypoxic–ischemic brain damage severity in a piglet survival model
Pediatric Research, Vol. 85, Núm. 4, pp. 539-545
2017
-
Neuroprotective effects of cannabidiol in hypoxic ischemic insult. The therapeutic window in newborn mice
CNS and Neurological Disorders - Drug Targets, Vol. 16, Núm. 1, pp. 102-108
2013
-
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors
Neuropharmacology, Vol. 71, pp. 282-291
2012
-
β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors
British Journal of Pharmacology, Vol. 166, Núm. 4, pp. 1474-1489
2011
-
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: An intravital microscopy study
Journal of Neuroinflammation, Vol. 8
-
The impact of clinical maternal chorioamnionitis on neurological and psychological sequelae in very-low-birth weight infants: A case-control study
Journal of Perinatal Medicine, Vol. 39, Núm. 2, pp. 203-208
2010
-
The endocannabinoid system and amyloid-related diseases
Experimental Neurology, Vol. 224, Núm. 1, pp. 66-73
-
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440
2009
-
Cannabinoids and neurodegenerative diseases
CNS and Neurological Disorders - Drug Targets, Vol. 8, Núm. 6, pp. 440-450
-
Codificación en neurología pediátrica basada en la Clasificación Internacional de Enfermedades, 9. a revisión (CIE-9), 5. a edición (2006)
Revista de Neurologia, Vol. 48, Núm. 2, pp. 58-60
-
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
Brain Research, Vol. 1283, pp. 148-154
2008
-
Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets
Pediatric Research, Vol. 64, Núm. 6, pp. 653-658
2007
-
Agenesia traqueal asociada a malformaciones laríngeas como causa inusual de fracaso de la vía aérea
Anales de Pediatria, Vol. 67, Núm. 3, pp. 236-239
-
Terapia de grupo para el tratamiento de la obesidad infantil
Anales de Pediatria, Vol. 67, Núm. 1, pp. 51-56
-
The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats
Pediatric Research, Vol. 62, Núm. 3, pp. 255-260
-
The seek of neuroprotection: Introducing cannabinoids
Recent Patents on CNS Drug Discovery, Vol. 2, Núm. 2, pp. 131-139
2006
-
Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats
Pediatric Research, Vol. 60, Núm. 2, pp. 169-173
-
Nitric oxide synthase as a target for the prevention of hypoxic-ischemic newborn brain damage
Current Enzyme Inhibition, Vol. 2, Núm. 3, pp. 219-229